3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
1
Prolactinoma
1
Pituitary ACTH Hypersecretion
1
Paraproteinemias
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mesothelioma, Malignant
1
Immunoglobulin Light-chain Amyloidosis
1
Head and Neck Neoplasms
1
Gigantism
1
Congenital Abnormalities
1
Combined Pituitary Hormone Deficiency
1
Carcinogenesis
1
Acromegaly
1
Interventions
X-Rays
7
Phantoms, Imaging
7
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Nuclear Medicine Department, Hospital
5
Biopsy
5
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Temozolomide
2
LY3023414
2
Fluorouracil
2
Doxorubicin
2
Cisplatin
2
Carboplatin
2
talazoparib
1
sodium thiosulfate
1
pembrolizumab
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
cabozantinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hepatoblastoma
×
Tissue Banks
×
90 days
×
Clear all
No trials found.